You are here

Article metrics

Article menu

Download PDFPDF

Clinical Trials Monitor
Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy

 

Online download statistics by month:

Online download statistics by month: December 2019 to September 2024

AbstractFullPdf
Dec 2019110
Jan 2020330
Feb 202025265
Mar 202055558
Apr 202037377
May 2020949410
Jun 202059594
Jul 202031316
Aug 202017173
Sep 202074744
Oct 2020777713
Nov 202011211323
Dec 202011511510
Jan 202116316329
Feb 202115515638
Mar 202120620629
Apr 202116116118
May 202117117151
Jun 202112812828
Jul 202110610624
Aug 2021888818
Sep 202113313319
Oct 202115315322
Nov 202122522327
Dec 202124224735
Jan 202217018026
Feb 202214214932
Mar 202220721629
Apr 202222022531
May 202225528640
Jun 202214516123
Jul 202215417335
Aug 202240240729
Sep 202280180725
Oct 202233135144
Nov 202232732535
Dec 202218318319
Jan 202319319830
Feb 202314414719
Mar 202318018319
Apr 202314214716
May 202314515025
Jun 202311111113
Jul 202311011119
Aug 202313713721
Sep 202319019114
Oct 202329629913
Nov 202347948428
Dec 202323123228
Jan 2024808112
Feb 202417917929
Mar 202423523621
Apr 202427627744
May 202413513514
Jun 202413113013
Jul 202413613925
Aug 202412212333
Sep 202411912123
Total973999111258